| BRAF vs RAS oncogenes: are mutations of the same pathway equal? Differential signalling and therapeutic implications E Oikonomou, E Koustas, M Goulielmaki, A Pintzas Oncotarget 5 (23), 11752, 2014 | 123 | 2014 |
| Mesenchymal stem cells in preclinical cancer cytotherapy: a systematic review I Christodoulou, M Goulielmaki, M Devetzi, M Panagiotidis, G Koliakos, ... Stem Cell Research & Therapy 9, 1-38, 2018 | 104 | 2018 |
| [Comment] The COVID‑19 pandemic as a scientific and social challenge in the 21st century V Zoumpourlis, M Goulielmaki, E Rizos, S Baliou, DA Spandidos Molecular medicine reports 22 (4), 3035-3048, 2020 | 103 | 2020 |
| BRAF associated autophagy exploitation: BRAF and autophagy inhibitors synergise to efficiently overcome resistance of BRAF mutant colorectal cancer cells M Goulielmaki, E Koustas, E Moysidou, M Vlassi, T Sasazuki, ... Oncotarget 7 (8), 9188, 2016 | 70 | 2016 |
| Significance of taurine transporter (TauT) in homeostasis and its layers of regulation S Baliou, AM Kyriakopoulos, M Goulielmaki, MI Panayiotidis, ... Molecular medicine reports 22 (3), 2163-2173, 2020 | 54 | 2020 |
| Drug nanocarriers for cancer chemotherapy based on microemulsions: The case of Vemurafenib analog PLX4720 I Theochari, M Goulielmaki, D Danino, V Papadimitriou, A Pintzas, ... Colloids and Surfaces B: Biointerfaces 154, 350-356, 2017 | 47 | 2017 |
| Historical retrospective of the SRC oncogene and new perspectives A Simatou, G Simatos, M Goulielmaki, DA Spandidos, S Baliou, ... Molecular and clinical oncology 13 (4), 1-1, 2020 | 29 | 2020 |
| Genetically‑modified stem cells in treatment of human diseases: Tissue kallikrein (KLK1)‑based targeted therapy M Devetzi, M Goulielmaki, N Khoury, DA Spandidos, G Sotiropoulou, ... international journal of molecular medicine 41 (3), 1177-1186, 2018 | 28 | 2018 |
| DPS-2: a novel dual MEK/ERK and PI3K/AKT pathway inhibitor with powerful ex vivo and in vivo anticancer properties M Goulielmaki, N Assimomytis, J Rozanc, E Taki, I Christodoulou, ... Translational Oncology 12 (7), 932-950, 2019 | 17 | 2019 |
| Promising biomarkers in head and neck cancer: The most clinically important miRNAs AC Thomaidou, P Batsaki, M Adamaki, M Goulielmaki, CN Baxevanis, ... International journal of molecular sciences 23 (15), 8257, 2022 | 16 | 2022 |
| Encapsulation of cannabidiol in oil-in-water nanoemulsions and nanoemulsion-filled hydrogels: A structure and biological assessment study S Demisli, E Galani, M Goulielmaki, FL Kyrilis, T Ilić, F Hamdi, M Crevar, ... Journal of Colloid and Interface Science 634, 300-313, 2023 | 14 | 2023 |
| Carbon quantum dots/block copolymer ensembles for metal-ion sensing and bioimaging T Skaltsas, M Goulielmaki, A Pintzas, S Pispas, N Tagmatarchis Journal of materials chemistry B 5 (27), 5397-5402, 2017 | 11 | 2017 |
| DNA damage response mechanisms in head and neck cancer: significant implications for therapy and survival C Papalouka, M Adamaki, P Batsaki, P Zoumpourlis, A Tsintarakis, ... International Journal of Molecular Sciences 24 (3), 2760, 2023 | 10 | 2023 |
| Rational design of aqueous conjugated polymer nanoparticles as potential theranostic agents of breast cancer P Koralli, S Tsikalakis, M Goulielmaki, S Arelaki, J Müller, AD Nega, ... Materials Chemistry Frontiers 5 (13), 4950-4962, 2021 | 9 | 2021 |
| T-Cell Repertoire in Tumor Radiation: The Emerging Frontier as a Radiotherapy Biomarker CN Baxevanis, AD Gritzapis, IF Voutsas, P Batsaki, M Goulielmaki, ... Cancers 14 (11), 2674, 2022 | 6 | 2022 |
| Bromamine T (BAT) exerts stronger anti-cancer properties than taurine (Tau) S Baliou, M Goulielmaki, P Ioannou, C Cheimonidi, IP Trougakos, M Nagl, ... Cancers 13 (2), 182, 2021 | 6 | 2021 |
| miRNA-guided regulation of mesenchymal stem cells derived from the umbilical cord: paving the way for stem-cell based regeneration and therapy AC Thomaidou, M Goulielmaki, A Tsintarakis, P Zoumpourlis, M Toya, ... International Journal of Molecular Sciences 24 (11), 9189, 2023 | 5 | 2023 |
| The thin red line between the immune system and cancer evolution CN Baxevanis, M Goulielmaki, M Adamaki, SP Fortis Translational Oncology 27, 101555, 2023 | 5 | 2023 |
| Radiotherapy-related gene signature in prostate cancer P Kogionou, SP Fortis, M Goulielmaki, N Aubert, P Batsaki, S Ouzounis, ... Cancers 14 (20), 5032, 2022 | 5 | 2022 |
| The impact of radiation therapy on the TCR Vβ chain repertoire in patients with prostate cancer M Goulielmaki, N Davanos, P Kogionou, P Batsaki, S Stokidis, M Adamaki, ... International Journal of Oncology 60 (6), 1-12, 2022 | 5 | 2022 |
